What is ATC/DDD ?

  • TSUTANI Kiichiro
    Department of Pharmacoeconomics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan
  • IGARASHI Ataru
    Department of Pharmacoeconomics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan
  • MORIKAWA Kaoru
    Division of Safety Information on Drug, Food and Chemicals, National Institute of Health Sciences, Japan

Bibliographic Information

Other Title
  • ATC/DDDとは何か
  • Towards a More Rational Use of Drugs
  • 医薬品の合理的使用を目指すものさし

Search this article

Description

The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD) as a measuring unit was developed along with an increased concern about drug utilization studies in Europe in the 1960s. Its use was recommended by the WHO Regional Office of Europe on 1981, then by the WHO Headquarters in Geneva in 1996. It is maintained by the WHO Collaborating Centre on Drug Statistics Methodology in Olso (http://www.whocc.no/) and widely used in Europe. However, it is rarely used in other parts of the world. This paper aims to inform the Japanese public about the ATC/ DDD system towards a more rational use of drugs in Japan. It attempts to answer the five Ws on ATC/ DDD, i.e., “What is ATC/DDD?”; “Why is ATC/DDD used?”; “When was ATC/DDD established?”; “Who decide ATC/DDD and how?”; and “Where is ATC/DDD used?”

Journal

Citations (2)*help

See more

Details 詳細情報について

  • CRID
    1390282679459290624
  • NII Article ID
    130004345391
  • DOI
    10.3820/jjpe1996.9.53
  • ISSN
    1882790X
    13420445
    http://id.crossref.org/issn/13420445
  • Data Source
    • JaLC
    • Crossref
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top